🔎 Trials Near Me

Akèy › Dematit atopik (Ekzema) › Florid › Miami

Etid klinik pou Dematit atopik (Ekzema) nan Miami, FL

9 etid pou Dematit atopik (Ekzema) ap chèche patisipan nan sit nan ak bò kote Miami (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

Ph 1a/1b Single Ascending Dose and Multiple Ascending Dose Study of ARQ-234

Ap rekriteFaz 1Volontè an sante akeyi
  • Clinical Site 110, Miami
Laj 18 a 65 · Tout sèks · Mizajou Sep 29, 2026 · NCT07453602

Platform Study to Evaluate the Efficacy and Safety of Investigational Compound(s) in Patients With Moderate to Severe Atopic Dermatitis

Ap rekriteFaz 2
  • Novartis Investigative Site, Miami
Laj 18 a 100 · Tout sèks · Mizajou Sep 28, 2026 · NCT06947993

Study of ENV-294 in Adults With Moderate-to-Severe Atopic Dermatitis

Ap rekriteFaz 2
  • Enveda Investigative Site, Miami
Laj 18 a 75 · Tout sèks · Mizajou Sep 25, 2026 · NCT07298395

A Phase 2b Study of the Effects of Camoteskimab in Adults With Moderate-to-Severe Atopic Dermatitis

Ap rekriteFaz 2
  • Quality Care Clinical Research, Miami
  • FXM Clinical Research Miami, LLC, Miami
Laj 18 a 65 · Tout sèks · Mizajou Aug 28, 2026 · NCT07599813

FIH Study to Evaluate the Tolerability of PF-07832837 in Healthy Adults and Patients

Ap rekriteFaz 1Volontè an sante akeyi
  • Miami Dermatology and Laser Research, Miami
Laj 18 a 70 · Tout sèks · Mizajou Jul 22, 2026 · NCT06564389

A Trial to Evaluate the Efficacy and Safety of Tralokinumab in Combination With Topical Corticosteroids in Children and Infants With Moderate-to-severe Atopic Dermatitis

Ap rekriteFaz 3
  • Leo Pharma Investigational site, Miami
6 Months – 11 Years · Tout sèks · Mizajou Jul 7, 2026 · NCT06311682

A Study of Upadacitinib in Adult Participants With Moderate-to-Severe Atopic Dermatitis and Inadequate Response to Dupilumab

Ap rekriteFaz 3
  • Research Associates of South Florida /ID# 267291, Miami
  • International Dermatology Research /ID# 264961, Miami
  • FAX Pharma Clinical Research /ID# 280915, Miami
  • ak 2 plis
Laj 18 a 63 · Tout sèks · Mizajou Jul 6, 2026 · NCT06389136

A Study To Learn About Two Study Medicines (PF-07275315 And PF-07264660) In People Who Have Moderate To Severe Atopic Dermatitis

Ap rekriteFaz 2
  • Floridian Research Institute Llc, Miami
Laj 18 ak plis · Tout sèks · Mizajou May 4, 2026 · NCT05995964

Real-world Experience Using Nemolizumab in the Treatment of Moderate-to-Severe Atopic Dermatitis in Adolescents & Adults

Ap rekriteEtid obsèvasyon
  • Galderma Investigational Site 7078, Miami
Laj 12 ak plis · Tout sèks · Mizajou Mar 13, 2026 · NCT06988605

Etid Dematit atopik (Ekzema) nan lòt vil

Lòt etid nan Miami

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.